2026-08-13T08:17:27+00:00 2025-09-30 346565596 ERNST & YOUNG US LLP 18101 VON KARMAN AVENUE IRVINE CA 92612 990 2024-10-01 274803222 CITY OF HOPE MEDICAL FOUNDATION CITY 6262564673 1500 EAST DUARTE ROAD DUARTE CA 91010 YVETTE TREMONTI TREASURER & CFO 6262564673 2026-08-13 true true KARA ADAMS P00023315 9497942300 2026-07-25 2024 2025-03-06 01:10:19Z VINCE JENSEN 1500 EAST DUARTE ROAD DUARTE CA 91010 812546410 false X CITYOFHOPE.ORG X 2011 CA TO PROVIDE MEDICAL CARE FOR PEOPLE WITH CANCER, DIABETES AND OTHER LIFE-THREATENING DISEASES AS PART OF A COORDINATED HEALTHCARE DELIVERY SYSTEM OPERATED BY CITY OF HOPE. 7 4 815 56 163979 30130 8000000 8031912 780862977 803789571 0 467460 724927 789330437 812546410 0 0 89976259 95709448 0 0 683910462 721331073 773886721 817040521 15443716 -4494111 860803156 956356452 535708523 635755930 325094633 320600522 ESTABLISH, ACQUIRE, OPERATE AND MAINTAIN OUTPATIENT CLINICS AND OTHER HEALTH CARE FACILITIES AND OPERATIONS FOR TREATING THOSE SUFFERING FROM CANCER AND OTHER LIFE-THREATENING DISEASES. PLEASE SEE SCHEDULE O FOR A CONTINUATION OF OUR MISSION. false false 644369378 0 803789571 AS PART OF A COORDINATED HEALTH CARE DELIVERY SYSTEM IN SOUTHERN CALIFORNIA, MEDICAL FOUNDATION OPERATES IN OVER 25 LOCATIONS IN FIVE COUNTIES, AND PROVIDES OR ARRANGES FOR THE PROVISION OF MEDICAL CARE AND TREATMENT OF PERSONS SUFFERING FROM CANCER AND OTHER LIFE-THREATENING DISEASES. AS PART OF CITY OF HOPE'S MISSION OF CREATING GREATER INTEGRATION AND COORDINATION OF PATIENT CARE, RESEARCH AND EDUCATION SERVICES, MEDICAL FOUNDATION ALSO PROVIDES OR ARRANGES FOR THE PROVISION OF CERTAIN PATIENT CARE AND ON-CALL COVERAGE SERVICES, RESEARCH, TEACHING AND ADMINISTRATIVE SERVICES TO MEDICAL CENTER. THROUGH THESE CLINICS AND VARIOUS AGREEMENTS, MEDICAL CENTER IS ABLE TO ENSURE THAT PATIENT CARE, AS WELL AS ACCOMPANYING CLINICAL RESEARCH AND COMMUNITY EDUCATION, IS PROVIDED SEAMLESSLY THROUGH A FULLY INTEGRATED NETWORK OF PROVIDERS. MEDICAL FOUNDATION AND MEDICAL CENTER AIM TO CONTINUE TO BROADEN THE AVAILABILITY OF HEALTH CARE AND CLINICAL RESEARCH SERVICES FOR VULNERABLE POPULATIONS INCLUDING MEDICARE AND MEDI-CAL BENEFICIARIES AND CHARITY CARE PATIENTS. CITY OF HOPE MAKES A RANGE OF SERVICES AVAILABLE TO BENEFICIARIES OF THESE PROGRAMS ON A NON-DISCRIMINATORY BASIS WITHIN ITS INPATIENT AND OUTPATIENT FACILITIES, INCLUDING MEDICAL CENTER AND MEDICAL FOUNDATION, AND MAKES SIGNIFICANT INVESTMENTS IN COMMUNITY BENEFIT ACTIVITIES. MEDICAL FOUNDATION PARTICIPATES IN THESE ACTIVITIES CONSISTENT WITH ITS CHARITABLE PURPOSES. MEDICAL FOUNDATION PLAYS AN INTEGRAL ROLE IN ENSURING THE COORDINATION AND AVAILABILITY OF RESEARCH TO BENEFIT PATIENT CARE. THROUGH MEDICAL FOUNDATION, ACCESS TO CLINICAL TRIALS AND DRUG STUDIES ARE MADE AVAILABLE TO A WIDER BASE OF PATIENTS WHO WISH TO REMAIN IN THE COMMUNITY TO RECEIVE THEIR SPECIALIZED CARE. MEDICAL CENTER OFFERS ACCREDITED TRAINING PROGRAMS AND SERVICES THAT SERVE STUDENTS, POSTDOCTORAL TRAINEES, PHYSICIANS, NURSES AND OTHER HEALTH-CARE PROFESSIONALS. MEDICAL FOUNDATION SUPPORTS THESE PROGRAMS BY PROVIDING PROFESSIONAL PROVIDERS WHO SERVE AS SUPERVISORS AND MENTORS FOR PARTICIPANTS IN SUCH TRAINING AND THROUGH THE VARIOUS RESEARCH, TEACHING, AND ADMINISTRATIVE SERVICES PROVIDED BY THE FOUNDATION. MEDICAL FOUNDATION ALSO ASSISTS IN COMMUNITY EDUCATION AND DISEASE PREVENTION PROGRAMS. 644369378 true true false false false false false false false false true false false true true true false true false false false false false false false false false false false true false false false false false false false false false false false false false false false true true true false false true X 35 0 true 815 true true true false false false false false false false false false true false X 7 4 true false false false true true true true false false false false false true true true true true true true true true CA X YVETTE TREMONTI 6262564673 1500 EAST DUARTE ROAD DUARTE CA 91010 MORGAN CHU ESQ DIRECTOR & CHAIR OF THE BOARD 3.0 12.0 X X 0 0 0 VINCENT D JENSEN DIRECTOR/COHMF CHIEF EXECUTIVE 30.0 30.0 X X 592657 592658 108635 EDWARD S KIM DIRECTOR, SYSTEM CLIN TRIALS 2.0 60.0 X 0 1624859 111694 MARY CIANFROCCA DO DIRECTOR 2.0 0 X 0 0 0 NISHAN TCHEKMEDYIAN MD DIRECTOR 2.0 0 X 0 0 0 RANDY TAPLITZ MD DIRECTOR 2.0 0 X 0 0 0 RAVI SALGIA MD PHD DIRECTOR 2.0 0 X 0 0 0 VIJAY TRISAL MD SYSTEM CHIEF CLINICAL OFFICER 2.0 58.0 X 41527 1216878 131514 CRISTIN OCALLAHAN SECRETARY/GENERAL COUNSEL 10.0 50.0 X 216808 1138243 250963 DONALD J MATTHEWSON ASSISTANT TREASURER/VP, TREASURY & FINANCIAL STRATEGY 12.0 48.0 X 123785 495140 40195 JO ANN ESCASA-HAIGH ASSISTANT TREASURER/CHIEF BUSINESS OFFICER 12.0 48.0 X 398030 1592119 257551 YVETTE TREMONTI TREASURER/CHIEF FINANCIAL OFFICER 10.0 50.0 X 138263 725881 88040 DEBRA F FIELDS EXEC VP & CHIEF TRANSFORMATION OFC 12.0 48.0 X 386638 1546554 295329 KEVIN MANEMANN EVP & CHIEF INTEGRATION OFFCR 15.0 45.0 X 447510 1342529 227089 ROBERT W STONE PRESIDENT & CEO 4.0 56.0 X 407739 5677911 1030210 SIMON NAZARIAN CHIEF DIGITAL OFFICER 12.0 48.0 X 179376 717504 38928 ANNETTE M WALKER PRESIDENT OF COH OC CANCER CTR 6.0 54.0 X 187425 1686828 275724 HARLAN ALCON LEVINE PRES, HLTH INNOVATION & POLICY 11.0 49.0 X 403547 1801628 291670 KRISTIN BERTELL CHIEF PHILANTHROPY OFFICER 2.0 58.0 X 45571 1335377 240476 LLOYD SILBERSTEIN SVP, CHF CONST & PLANNING 15.0 45.0 X 353419 1060257 98080 MARCELLUS R VAN DEN BRINK MD PHD COHNMC PRESIDENT & CHF PHYS EXEC 4.0 56.0 X 154002 2046030 369982 JENNIFER PARKHURST FORMER OFFICER 0.0 0.0 X 242399 969596 38026 MARK HULSE FORMER CHIEF DIGITAL OFFICER 0.0 0.0 X 59542 238166 15439 4378238 25808158 3909545 156 true true false CITY OF HOPE MEDICAL GROUP INC 1500 EAST DUARTE ROAD DUARTE CA 91010 PROFESSIONAL SERVICES 348615860 PACIFIC CONSTRUCTION GROUP 17895 SKY PARK CIRCLE UNIT K IRVINE CA 92614 CONSTRUCTION SERVICES 736444 VARIAN MEDICAL SYSTEMS INC 70140 NETWORK PLACE CHICAGO IL 60673 MEDICAL TECHNOLOGY 659500 LEANTAAS INC DEPT LA 24741 PASADENA CA 91185 MANAGEMENT SERVICES 619617 ENVIRONMENT CONTROL PUENTE HILLS INC 570 W LAMBERT RD SUITE A BREA CA 92821 COMMERCIAL CLEANING 521694 20 8031912 8031912 NET PATIENT REVENUE 621110 560393935 560393935 RESEARCH, TEACHING, & ADMINISTRATIVE 541700 175484141 175484141 PHARMACY REVENUE 900099 61557893 61557893 OTHER EXEMPT FUNCTION REVENUE 621110 6353602 6353602 0 0 0 0 803789571 12000 12000 0 12000 12000 0 0 NON-INVESTMENT INTEREST INCOME 900099 398565 398565 OUTREACH LAB 621110 163979 163979 OTHER MISC. REVENUE 900099 150383 150383 0 0 0 0 712927 812546410 803789571 163979 560948 X 3461969 1759417 1702552 71075885 36121672 34954213 2287036 1162301 1124735 9509755 4832979 4676776 9374803 4764394 4610409 367115 367115 81976 81976 427541152 323566613 103974539 0 458112 287091 171021 4339907 3381726 958181 5810178 4352456 1457722 9292770 2656850 6635920 501006 143240 357766 73890 21685 52205 1627 1627 10845849 6209949 4635900 2004262 573029 1431233 PHARMACEUTICALS 250434924 249682799 752125 LAB/MEDICAL SUPPLIES & EQUIPMENT 3023524 2975843 47681 REPAIRS & MAINTENANCE 2180844 626248 1554596 LEGAL SETTLEMENT 1456062 416296 1039766 2917875 834790 2083085 0 817040521 644369378 172671143 0 35429981 32680087 46916828 27583490 0 0 0 0 4832877 6015604 651808 516499 85954245 50743922 45497740 35210323 0 17258065 13439210 32479626 27726510 677736231 813184729 860803156 956356452 66745404 79330180 7425 7425 0 0 468955694 556418325 535708523 635755930 X 325094633 320600522 325094633 320600522 860803156 956356452 -4494111 0 X false true true true true X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 11011795 11011795 9893453 1366475 8526978 31847554 24413489 7434065 30158285 24963958 5194327 3043158 0 3043158 35210323 DUE FROM AFFILIATES 794995543 RIGHT-OF-USE OP. LEASE ASSETS 10483248 WORKERS COMPENSATION RECEIVABLE 4076229 OTHER ASSETS 3560685 RIGHT-OF-USE FINANCE LEASE 69024 813184729 FEDERAL INCOME TAXES DUE TO AFFILIATES 537878562 RIGHT-OF-USE OP. LEASE LIABILITIES 13614038 SELF-INSURANCE LIABILITIES 4925725 556418325 X 0 0 0 0 0 0 0 0 0 0 0 0 SCHEDULE D, PART X, LINE 2 FIN 48 (ASC 740) FOOTNOTE THE FOLLOWING PARAGRAPH IS FROM THE CITY OF HOPE CONSOLIDATED AUDITED FINANCIAL STATEMENTS AS OF SEPTEMBER 30, 2025 (WHICH INCLUDES CITY OF HOPE, CITY OF HOPE NATIONAL MEDICAL CENTER (THE "CENTER"), CITY OF HOPE MEDICAL FOUNDATION (THE "FOUNDATION"), AND BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE (THE "INSTITUTE") (COLLECTIVELY, THE "OBLIGATED GROUP"); THE TRANSLATIONAL GENOMICS RESEARCH INSTITUTE AND ITS AFFILIATES ("TGEN"); SOUTHERN CALIFORNIA RADIATION ONCOLOGY, LLC ("SCRO"); ACCESSHOPE, LLC ("AH"); STEPHENSON GLOBAL PANCREATIC CANCER RESEARCH INSTITUTE, LLC; COH PROPERTY HOLDINGS OC, LLC; COH PROPERTY MANAGEMENT OC, LLC; AND COH HOLDCO, INC. ("HOLDCO"), THE PARENT OF CANCER TREATMENT CENTERS OF AMERICA ENTITIES ("CTCA ENTITIES") (COLLECTIVELY, THE "AFFILIATED GROUP"). THESE ENTITIES REPRESENT THE CONSOLIDATED CITY OF HOPE ORGANIZATION (COLLECTIVELY REFERRED TO AS "CITY OF HOPE")). CITY OF HOPE IS EXEMPT FROM FEDERAL INCOME TAX UNDER SECTION 501(A) AS DESCRIBED IN SECTION 501(C)(3) OF THE U.S. INTERNAL REVENUE CODE. CITY OF HOPE, THE CENTER, THE FOUNDATION, AND THE INSTITUTE ARE EXEMPT FROM CALIFORNIA STATE FRANCHISE AND INCOME TAX UNDER SECTION 23701(D) OF THE CALIFORNIA REVENUE AND TAXATION CODE. ASC 740, INCOME TAXES, CLARIFIES THE ACCOUNTING FOR INCOME TAXES BY PRESCRIBING A MINIMUM RECOGNITION THRESHOLD THAT A TAX POSITION IS REQUIRED TO MEET BEFORE BEING RECOGNIZED IN THE CONSOLIDATED FINANCIAL STATEMENTS. ASC 740 ALSO PROVIDES GUIDANCE ON DE-RECOGNITION, MEASUREMENT, CLASSIFICATION, INTEREST AND PENALTIES, DISCLOSURE, AND TRANSITION. THE GUIDANCE CONTAINED IN ASC 740 IS APPLICABLE TO PASS-THROUGH ENTITIES AND TAX-EXEMPT ORGANIZATIONS. CITY OF HOPE HAS NO SIGNIFICANT UNCERTAIN TAX POSITIONS OR TAX LIABILITY FOR TAX BENEFITS, INTEREST, OR PENALTIES ACCRUED AS OF SEPTEMBER 30, 2025 OR 2024. X true true X X X X X false true false false false false false true false VINCENT D JENSEN DIRECTOR/COHMF CHIEF EXECUTIVE 390783 390786 172803 172802 29071 29070 41921 41921 12396 12397 646974 646976 26570 26570 EDWARD S KIM DIRECTOR, SYSTEM CLIN TRIALS 0 1099617 0 440111 0 85131 0 74297 0 37397 0 1736553 0 53129 VIJAY TRISAL MD SYSTEM CHIEF CLINICAL OFFICER 26995 791047 12625 369939 1907 55892 3081 90285 1259 36889 45867 1344052 1833 53704 MARK HULSE FORMER CHIEF DIGITAL OFFICER 33299 133193 15000 60000 11243 44973 2012 8048 1076 4303 62630 250517 24005 96019 JENNIFER PARKHURST FORMER OFFICER 44218 176871 30000 120000 168181 672725 3228 12912 4377 17509 250004 1000017 15526 62103 JO ANN ESCASA-HAIGH ASSISTANT TREASURER/CHIEF BUSINESS OFFICER 235344 941376 159226 636903 3460 13840 46552 186207 4958 19834 449540 1798160 0 0 DONALD J MATTHEWSON ASSISTANT TREASURER/VP, TREASURY & FINANCIAL STRATEGY 93398 373592 24060 96240 6327 25308 5121 20484 2918 11672 131824 527296 0 0 CRISTIN OCALLAHAN SECRETARY/GENERAL COUNSEL 116400 611096 93225 489434 7183 37713 34583 181561 5571 29248 256962 1349052 20996 110228 YVETTE TREMONTI TREASURER/CHIEF FINANCIAL OFFICER 79463 417185 57374 301210 1426 7486 11102 58284 2984 15670 152349 799835 0 0 DEBRA F FIELDS EXEC VP & CHIEF TRANSFORMATION OFC 206881 827526 163120 652480 16637 66548 50425 201699 8641 34564 445704 1782817 42284 169136 KEVIN MANEMANN EVP & CHIEF INTEGRATION OFFCR 250999 752998 195165 585495 1346 4036 47517 142551 9255 27766 504282 1512846 0 0 SIMON NAZARIAN CHIEF DIGITAL OFFICER 58834 235338 120000 480000 542 2166 6458 25834 1327 5309 187161 748647 0 0 ROBERT W STONE PRESIDENT & CEO 145402 2024773 248748 3463902 13589 189236 67360 938015 1664 23171 476763 6639097 48308 672707 HARLAN ALCON LEVINE PRES, HLTH INNOVATION & POLICY 205521 917545 178207 795600 19819 88483 48838 218038 4537 20257 456922 2039923 42919 191608 KRISTIN BERTELL CHIEF PHILANTHROPY OFFICER 25161 737308 18701 547998 1709 50071 6642 194627 1294 37913 53507 1567917 5057 148178 LLOYD SILBERSTEIN SVP, CHF CONST & PLANNING 188487 565461 92333 276999 72599 217797 20595 61785 3925 11775 377939 1133817 4236 12708 MARCELLUS R VAN DEN BRINK MD PHD COHNMC PRESIDENT & CHF PHYS EXEC 104903 1393711 44866 596074 4233 56245 24281 322589 1618 21494 179901 2390113 0 0 ANNETTE M WALKER PRESIDENT OF COH OC CANCER CTR 98289 884612 78993 710933 10143 91283 25794 232147 1778 16005 214997 1934980 20511 184598 SCHEDULE J, PART I, LINE 1A FIRST-CLASS OR CHARTER TRAVEL MEDICAL FOUNDATION PERMITS FIRST CLASS TRAVEL FOR CERTAIN OFFICERS, DIRECTORS, AND KEY EXECUTIVES IN LIMITED CIRCUMSTANCES WHEN SPECIFIED TRAVEL CRITERIA ARE MET. SCHEDULE J, PART I, LINE 4B SUPPLEMENTAL NONQUALIFIED RETIREMENT PLAN CITY OF HOPE HAS A NON-QUALIFIED SECTION 457(F) EXECUTIVE SUPPLEMENTAL ACCUMULATION PLAN THAT IS DESIGNED AND MAINTAINED TO PROVIDE A SELECT GROUP OF MANAGEMENT OR HIGHLY COMPENSATED EMPLOYEES WITH DEFERRED COMPENSATION. THE PLAN VESTS AFTER THREE (3) FISCAL YEARS OF SERVICE AND THE VESTED TOTALS ARE INCLUDED IN SCHEDULE J, PART II, COLUMN (B) (III). PRIOR TO VESTING, THE ANNUAL CONTRIBUTION AMOUNTS ARE INCLUDED IN SCHEDULE J, PART II, COLUMN (C). PURSUANT TO THE PLAN DOCUMENT, VESTED PARTICIPANTS ARE ENTITLED TO WITHDRAW FROM THEIR VESTED ACCOUNT AN AMOUNT EQUAL TO THE FEDERAL, STATE, LOCAL AND FICA TAXES THEY OWE. THESE AMOUNTS ARE REMITTED TO THE APPROPRIATE TAXING AUTHORITIES ON BEHALF OF THE PARTICIPANTS. DURING CALENDAR YEAR 2024, NO INDIVIDUALS WITHDREW AMOUNTS TO COVER SUCH TAXES. SCHEDULE J, PART I, LINE 7 NON-FIXED PAYMENTS MEDICAL FOUNDATION'S EXECUTIVES AND CERTAIN KEY EMPLOYEES ARE ELIGIBLE TO RECEIVE INCENTIVE COMPENSATION UNDER AN ANNUAL INCENTIVE PLAN (AIP) TIED TO ORGANIZATIONAL KEY PERFORMANCE INDICATORS AND INDIVIDUAL OBJECTIVES. THE KEY PERFORMANCE INDICATORS REFLECT KEY AREAS OF STRATEGIC FOCUS AND THE EXEMPT HEALTHCARE MISSION OF CITY OF HOPE AND AFFILIATES AND ARE BOTH FINANCIAL AND NON-FINANCIAL. THE POTENTIAL INCENTIVE COMPENSATION IS BASED ON A WEIGHTED AVERAGE AMONG ALL INDICATORS AND IS PAID AS A PERCENTAGE OF EACH INDIVIDUAL PARTICIPANT'S BASE COMPENSATION. THE KEY PERFORMANCE INDICATORS ARE WEIGHTED BASED ON THE PARTICIPANT'S PRIMARY AREA(S) OF RESPONSIBILITY, WITH ORGANIZATIONAL KEY PERFORMANCE INDICATORS WEIGHTED FROM 70 PERCENT TO 90 PERCENT, AND THE INDIVIDUAL OBJECTIVES WEIGHTED FROM 10 PERCENT TO 30 PERCENT. THE AIP IS UNDER THE CONTROL OF, AND ADMINISTERED BY, THE INDEPENDENT DIRECTORS SERVING ON THE EXECUTIVE COMPENSATION AND GOVERNANCE COMMITTEE. TO BE ELIGIBLE, THE PARTICIPANTS IN THE AIP MUST BE EMPLOYED BY CITY OF HOPE AT THE TIME OF THE INCENTIVE PLAN PAYMENT, AND BE MEETING OR EXCEEDING PERFORMANCE EXPECTATIONS. CITY OF HOPE MAY, IN ITS DISCRETION, CANCEL ALL OR A PORTION OF ANY INCENTIVE PLAN PAYMENT OR AWARD TO ANY PARTICIPANT, WHETHER BEFORE OR FOLLOWING PAYMENT OF SUCH AWARD, SUBJECT TO COMPLIANCE WITH APPLICABLE LAW, UNDER THE FOLLOWING CIRCUMSTANCES (CANCELLATION POLICY): A) AN INCENTIVE PLAN PAYMENT OR AWARD IS MADE FOR A FISCAL PERIOD AND CITY OF HOPE SUBSEQUENTLY RESTATES OR OTHERWISE ADJUSTS THE ANNUAL PERFORMANCE MEASUREMENT CALCULATION IN A MANNER THAT WOULD REDUCE THE SIZE OF THE AWARD OR PAYMENT, OR; B) AN INCENTIVE PLAN PAYMENT OR AWARD IS MADE FOR A FISCAL PERIOD AND CITY OF HOPE SUBSEQUENTLY DETERMINES THAT ONE OF MORE OF THE ANNUAL PERFORMANCE MEASUREMENT CALCULATIONS ON WHICH THE AWARD IS BASED OR IS PAID ARE MATERIALLY INACCURATE. THE AIP INCENTIVE COMPENSATION EARNED FOR FISCAL YEAR 2024 WAS PAID IN CALENDAR YEAR 2024 AND THESE AMOUNTS HAVE BEEN REPORTED IN SCHEDULE J, PART II, COLUMN (B)(II). MEDICAL FOUNDATION ALSO HAS AN EXECUTIVE LONG-TERM INCENTIVE (LTI) PLAN FOR CERTAIN EXECUTIVES THAT IS DESIGNED TO DRIVE LONG-TERM ORGANIZATIONAL PERFORMANCE AND TRANSFORMATION BY ALIGNING EXECUTIVES WITH THE MULTI-YEAR STRATEGIC PLAN AND INCENTIVIZING THEM FOR ACHIEVING KEY ORGANIZATIONAL AND STRATEGIC OBJECTIVES AND GOALS. WITH THREE-YEAR VESTING PERIODS, THE PLAN ALSO PROVIDES A MEANS FOR RETAINING KEY EXECUTIVE TALENT. THE PERFORMANCE PERIOD OF THE PLAN (CYCLE 10) RAN FROM OCTOBER 1, 2021 THROUGH SEPTEMBER 30, 2024 WITH A NEW THREE-YEAR PERFORMANCE PERIOD BEGINNING EACH OCTOBER 1ST THEREAFTER (E.G., CYCLE 11 RUNS FROM OCTOBER 1, 2022 THROUGH SEPTEMBER 30, 2025). TO BE ELIGIBLE TO PARTICIPATE IN ANY PAYOUT UNDER THE PLAN, PARTICIPANTS MUST BE ACTIVELY EMPLOYED BY CITY OF HOPE AT THE TIME OF THE INCENTIVE PLAN PAYMENT, AND BE MEETING OR EXCEEDING PERFORMANCE EXPECTATIONS. WHILE THE PLAN DOES MEET THE REQUIREMENTS FOR A SUBSTANTIAL RISK OF FORFEITURE, AS OF THE CALENDAR YEAR ENDING DECEMBER 31, 2024, THE POTENTIAL LTI AMOUNTS HAVE BEEN ESTIMATED AND ACCRUED DURING THE CURRENT TAX YEAR AND ARE REPORTED AS DEFERRED COMPENSATION TO THE PLAN PARTICIPANTS IN SCHEDULE J, PART II, COLUMN (C). THE LTI PLAN IS SUBJECT TO THE SAME CANCELLATION POLICY AS THE AIP DESCRIBED PREVIOUSLY. PARTICIPANTS WHO MET THE ELIGIBILITY CRITERIA RECEIVED A PAYOUT OF PLAN CYCLE 10 LTI INCENTIVES (OCTOBER 1, 2021 THROUGH SEPTEMBER 30, 2024) IN DECEMBER 2024. THESE AMOUNTS HAVE BEEN REFLECTED IN SCHEDULE J, PART II, COLUMN (B)(II). FORM 990, PART III, LINE 1 ORGANIZATION'S MISSION CITY OF HOPE'S MISSION IS TO PROVIDE MEDICAL CARE AND TREATMENT AS PART OF A COORDINATED HEALTH CARE DELIVERY SYSTEM IN SOUTHERN CALIFORNIA. CITY OF HOPE MEDICAL FOUNDATION (MEDICAL FOUNDATION) PROVIDES THESE SERVICES FOR TREATING, ATTEMPTING TO CURE, AND CURING PERSONS WITH CANCER, DIABETES AND OTHER LIFE-THREATENING DISEASES. MEDICAL FOUNDATION PROVIDES THESE SERVICES TO CERTAIN PATIENTS THROUGH CHARITY CARE ASSISTANCE FOR PATIENTS MEETING CERTAIN FINANCIAL ELIGIBILITY AND CLINICAL CRITERIA AND TO PERSONS WITHOUT INSURANCE OR WHO ARE UNDERINSURED. ALL SELF-PAY, UNDERINSURED, AND UNINSURED PATIENTS WHO DO NOT QUALIFY FOR CHARITY CARE UNDER MEDICAL FOUNDATION'S CHARITY CARE PROGRAM ARE OFFERED SERVICES THROUGH MEDICAL FOUNDATION AT DISCOUNTED CHARGES. THE DISCOUNT IS BASED ON A SET OF SPECIFIC QUALIFICATIONS, REGARDLESS OF THE SERVICES PROVIDED OR THE SETTING WHERE RENDERED TO THE RESPECTIVE PATIENT. MEDICAL FOUNDATION SUBSIDIZES CARE FOR PATIENTS COVERED BY MEDI-CAL AND MEDICARE. MEDICAL FOUNDATION WAS ALSO FORMED TO CONDUCT OR PARTICIPATE IN MEDICAL AND SCIENTIFIC INVESTIGATIONS AND RESEARCH INTO SUCH DISEASES; AND TO PROMOTE AND CARRY ON EDUCATIONAL ACTIVITIES RELATED TO THE HEALTH AND WELLBEING OF THE SICK AND DISABLED. MEDICAL FOUNDATION IS PART OF AN INTEGRATED SYSTEM THAT COMBINES BENCH AND CLINICAL RESEARCH ACTIVITIES DIRECTLY WITH PATIENT CARE, IN BOTH IN-PATIENT AND OUT-PATIENT SETTINGS. THIS INTEGRATED SYSTEM, KNOWN AS CITY OF HOPE, COLLECTIVELY REFERS TO CITY OF HOPE, CITY OF HOPE NATIONAL MEDICAL CENTER (MEDICAL CENTER), MEDICAL FOUNDATION, SOUTHERN CALIFORNIA RADIATION ONCOLOGY, LLC, BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE (BECKMAN RESEARCH INSTITUTE), THE TRANSLATIONAL GENOMICS RESEARCH INSTITUTE, THE TRANSLATIONAL GENOMICS RESEARCH INSTITUTE FOUNDATION, ACCESSHOPE, LLC, COH HOLDCO, INC., WESTERN REGIONAL MEDICAL CENTER, INC. (CITY OF HOPE PHOENIX), SOUTHEASTERN REGIONAL MEDICAL CENTER, INC. (CITY OF HOPE ATLANTA), AND MIDWESTERN REGIONAL MEDICAL CENTER, INC. (CITY OF HOPE CHICAGO). FORM 990, PART V, LINE 2A COMMON PAYMASTER ARRANGEMENT MOST OF CITY OF HOPE'S OFFICERS AND KEY EMPLOYEES, AS WELL AS A FEW OF ITS HIGHEST COMPENSATED EMPLOYEES, PROVIDE SERVICES TO MORE THAN ONE CITY OF HOPE ENTITY, AND MANY OF THEM PROVIDE SERVICES TO ALL OF THE ENTITIES. FOR A NUMBER OF THESE CONCURRENTLY EMPLOYED INDIVIDUALS, THE ENTITIES HAVE DESIGNATED MEDICAL CENTER AS A "COMMON PAYMASTER" DEFINED IN SECTION 3121(S) OF THE INTERNAL REVENUE CODE. CITY OF HOPE REPORTS THESE CONCURRENT EMPLOYEES' TIME, EFFORT AND COMPENSATION ON THE INFORMATION RETURNS OF CITY OF HOPE ENTITIES BASED ON THE INDIVIDUAL'S ESTIMATE OF THEIR TIME SPENT IN AND FOR EACH ENTITY. AS "COMMON PAYMASTER", MEDICAL CENTER ISSUES EACH OF THESE EMPLOYEES A SINGLE COMBINED PAYCHECK AND ONE FORM W-2. FORM 990, PART VI, LINE 2 FAMILY/BUSINESS RELATIONSHIPS AMONGST INTERESTED PERSONS RAVI SALGIA, M.D., RANDY TAPLITZ, M.D., AND MARY CIANFROCCA, D.O. - BUSINESS RELATIONSHIP FORM 990, PART VI, LINE 6 CLASSES OF MEMBERS OR STOCKHOLDERS CITY OF HOPE (FEIN: 95-3435919) IS THE SOLE CORPORATE MEMBER OF THE MEDICAL FOUNDATION. FORM 990, PART VI, LINE 7A MEMBERS OR STOCKHOLDERS ELECTING MEMBERS OF GOVERNING BODY CITY OF HOPE, AS THE SOLE CORPORATE MEMBER OF MEDICAL FOUNDATION, HAS THE POWER TO APPOINT INDIVIDUALS TO THE BOARD OF DIRECTORS OF MEDICAL FOUNDATION IN ACCORDANCE WITH THE PROCEDURES SET FORTH IN MEDICAL FOUNDATION'S BYLAWS. ADDITIONALLY, CITY OF HOPE MEDICAL GROUP, INC., (MEDICAL GROUP) AN UNRELATED, FOR-PROFIT CORPORATION, HAS THE ABILITY TO NOMINATE AND APPOINT PHYSICIAN MEMBERS TO THE BOARD OF DIRECTORS. THE PRESIDENT OF THE MEDICAL GROUP SERVES EX-OFFICIO AS A VOTING MEMBER OF THE BOARD OF DIRECTORS, AND THE TWO OTHER PHYSICIAN MEMBERS APPOINTED BY MEDICAL GROUP MUST EITHER MEET CERTAIN CRITERIA AS SPECIFIED IN THE BYLAWS OF MEDICAL FOUNDATION OR HAVE BEEN APPROVED BY THE SOLE CORPORATE MEMBER, CITY OF HOPE. FORM 990, PART VI, LINE 7B DECISIONS REQUIRING APPROVAL BY MEMBERS OR STOCKHOLDERS CERTAIN ACTIONS MAY NOT BE UNDERTAKEN WITHOUT THE PRIOR WRITTEN APPROVAL OF THE SOLE CORPORATE MEMBER, CITY OF HOPE, AS SPECIFIED IN THE GOVERNING DOCUMENTS OF MEDICAL FOUNDATION, INCLUDING: BORROWING MONEY IN THE NAME OF MEDICAL FOUNDATION OR UTILIZING PROPERTY OWNED BY MEDICAL FOUNDATION AS SECURITY FOR SUCH LOANS; ASSIGN, TRANSFER, PLEDGE, COMPROMISE OR RELEASE ANY OF THE CLAIMS OR DEBTS TO MEDICAL FOUNDATION EXCEPT ON PAYMENT IN FULL, OR ARBITRATE OR CONSENT TO THE ARBITRATION OF ANY DISPUTE OR CONTROVERSY OF MEDICAL FOUNDATION; MAKE, EXECUTE OR DELIVER ANY ASSIGNMENT FOR THE BENEFIT OF CREDITORS, OR ANY BOND, CONFESSION OF JUDGMENT, CHATTEL MORTGAGE, SECURITY AGREEMENT DEED, GUARANTY, INDEMNITY BOND, SURETY BOND, OR CONTRACT TO SELL OR BILL OF SALE OF THE PROPERTY OF MEDICAL FOUNDATION; ACQUIRE, PURCHASE, DEVELOP, IMPROVE, SELL, LEASE, OR MORTGAGE ANY CORPORATE REAL ESTATE OR ANY INTEREST THEREIN OR ENTER INTO ANY CONTRACT FOR ANY SUCH PURPOSES; MAKE ANY LOAN, INVESTMENT, TRANSFER OR DISPOSITION OF ANY ASSETS OF MEDICAL FOUNDATION OR ENTER INTO ANY CONTRACT OR INCUR ANY LIABILITIES BEHALF OF MEDICAL FOUNDATION OTHER THAN FOR FAIR CONSIDERATION AND THE ORDINARY COURSE OF BUSINESS RELATING TO ITS NORMAL DAILY OPERATIONS OR ESTABLISH CAPITAL AND OPERATING BUDGETS OR ADOPT MATERIAL CHANGES THERETO; OR ANY ACTION THAT COULD REASONABLY BE EXPECTED TO HAVE A MATERIAL ADVERSE EFFECT ON THE 501(C)(3) STATUS OF TAX-EXEMPT BONDS OF CITY OF HOPE. THE FOLLOWING ACTIONS REQUIRE GOVERNING BODY APPROVAL (AS WELL AS THE APPROVAL OF THE SOLE CORPORATE MEMBER): THE ADOPTION OF, OR MATERIAL CHANGE IN, THE MISSION OF MEDICAL FOUNDATION; SALE OR DISPOSITION OF ALL OR SUBSTANTIALLY ALL ASSETS; MERGER AND ITS PRINCIPAL TERMS (AND ANY AMENDMENT TO THOSE TERMS); DISSOLUTION OF THE CORPORATION; ADOPTION OF OPERATING AND CAPITAL BUDGETS; ACQUISITIONS AND CAPITAL EXPENDITURES MEETING A CERTAIN FINANCIAL THRESHOLD; BORROWINGS, GUARANTIES, LOAN, AND BOND ISSUANCE MEETING A CERTAIN FINANCIAL THRESHOLD; CREATION OF A NEW (OR ACQUISITION OF A CONTROLLING INTEREST IN AN EXISTING) CORPORATION, PARTNERSHIP OR LIMITED LIABILITY COMPANY; AND ADOPTION OF OR AMENDMENTS TO INDIVIDUAL CORPORATE INVESTMENT GUIDELINES. FORM 990, PART VI, LINE 8B DOCUMENTATION OF MEETINGS HELD BY COMMITTEES OF GOVERNING BODY THE MEDICAL FOUNDATION HAD NO COMMITTEES WITH THE AUTHORITY TO ACT ON BEHALF OF THE GOVERNING BODY. FORM 990, PART VI, LINE 11B REVIEW OF FORM 990 BY GOVERNING BODY A COPY OF THE FORM 990 IS REVIEWED BY THE RISK, AUDIT AND COMPLIANCE COMMITTEE OF THE BOARD OF DIRECTORS OF CITY OF HOPE, WHICH ASSISTS THE BOARD IN FULFILLING ITS RESPONSIBILITIES REGARDING FINANCIAL, ACCOUNTING, AND CORPORATE COMPLIANCE MATTERS OF MEDICAL FOUNDATION. THE FORM 990 INFORMATION IS COMPILED BY THE TAX TEAM AND PROVIDED TO EY, AN EXTERNAL ACCOUNTING FIRM, FOR THE PREPARATION OF FORM 990, WHICH IS REVIEWED THOROUGHLY WITH INTERNAL LEADERSHIP AND EXTERNAL PARTICIPANTS, INCLUDING EY. PRIOR TO FILING, THE MEDICAL FOUNDATION FORM 990 IS MADE AVAILABLE TO VOTING MEMBERS OF THE CITY OF HOPE BOARD OF DIRECTORS FOR REVIEW. FORM 990, PART VI, LINE 12C CONFLICT OF INTEREST POLICY ALL EMPLOYEES OF CITY OF HOPE AND AFFILIATES, BOARD OF DIRECTORS MEMBERS, BOARD COMMITTEE MEMBERS AND RESEARCH TEAM MEMBERS ARE COVERED BY CITY OF HOPE'S APPLICABLE CONFLICT OF INTEREST POLICIES. DETERMINATIONS AS TO WHETHER A CONFLICT OF INTEREST EXISTS AND REVIEW OF CONFLICT DISCLOSURES ARE MADE BY THE GENERAL COUNSEL AND CHIEF ETHICS AND COMPLIANCE OFFICER AND, AS APPLICABLE, THE CHAIR OF THE BOARD OR THE CONFLICT OF INTEREST AND COMMITMENT COMMITTEE, BASED UPON THE CLASSIFICATION OF PERSON MAKING THE DISCLOSURE. RESTRICTIONS IMPOSED ON PERSONS WITH A CONFLICT VARY, BASED UPON THE FACTS, AND MAY INCLUDE: PROHIBITION FROM PARTICIPATING IN A GOVERNING BODY'S DELIBERATIONS AND VOTING ON A GIVEN TRANSACTION OR SET OF TRANSACTIONS; RECUSAL FROM THE DECISION-MAKING PROCESS RELATING TO BUSINESS TRANSACTIONS (E.G., PURCHASING DECISIONS); PROHIBITION FROM PARTICIPATING AS A PRINCIPAL INVESTIGATOR IN RESEARCH; AND DISCLOSURE OF FINANCIAL INTEREST IN RESEARCH STUDY INFORMED CONSENT FORMS AND PUBLICATIONS. AS PART OF A CONFLICT MANAGEMENT PLAN, MONITORING TRANSACTIONS FOR CONFLICTS OF INTEREST IS DONE THROUGH REQUIRED DISCLOSURES AND UPDATES BY PERSONS COVERED BY THE ORGANIZATION'S CONFLICT OF INTEREST POLICIES AND A CONCURRENT REVIEW OF SUCH DISCLOSURES AGAINST TRANSACTIONS. CITY OF HOPE'S POLICY PROVIDES FOR DISCIPLINARY ACTION AGAINST PERSONS COVERED BY THE CONFLICT OF INTEREST POLICIES WHO DO NOT COMPLY WITH POLICY REQUIREMENTS. FORM 990, PART VI, LINE 15A PROCESS TO ESTABLISH COMPENSATION OF TOP MANAGEMENT OFFICIAL THE EXECUTIVE COMPENSATION AND GOVERNANCE COMMITTEE OF THE CITY OF HOPE BOARD OF DIRECTORS ("COMMITTEE"), PURSUANT TO A DELEGATION OF AUTHORITY FROM THE CITY OF HOPE BOARD OF DIRECTORS AND THE MEDICAL FOUNDATION BOARD OF DIRECTORS, IS RESPONSIBLE FOR APPROVING COMPENSATION OF THE TOP MANAGEMENT OFFICIAL WHERE THE PROPOSED COMPENSATION EXCEEDS CERTAIN THRESHOLDS ESTABLISHED BY THE COMMITTEE. THE DIRECTORS ON THIS COMMITTEE ARE INDEPENDENT AND ADHERE TO A STRICT CONFLICT OF INTEREST POLICY. DELIBERATION AND DECISION MAKING ARE SUBSTANTIATED IN THE MINUTES OF THE COMMITTEE'S MEETINGS. THE MINUTES ARE REVIEWED AND APPROVED AT THE NEXT MEETING OF THE COMMITTEE. AS PART OF THE DELIBERATION PROCESS, THE COMMITTEE RECEIVES ADVICE FROM AN INDEPENDENT, THIRD-PARTY COMPENSATION CONSULTANT WITH RESPECT TO EXECUTIVE COMPENSATION, INCLUDING REVIEW OF COMPARABLE AND BENCHMARK DATA, CURRENT COMPENSATION PHILOSOPHY, STRUCTURE, AND ADMINISTRATION OF THE EXECUTIVE CASH COMPENSATION PROGRAMS AT CITY OF HOPE AND AFFILIATES. THE COMMITTEE CARRIES OUT THE BOARD OF DIRECTOR'S OVERALL RESPONSIBILITIES RELATING TO EXECUTIVE COMPENSATION. THE EXECUTIVE COMPENSATION PHILOSOPHY IS DESIGNED TO ASSIST IN ATTRACTING AND RETAINING THE CALIBER OF EXECUTIVE LEADERSHIP REQUIRED TO ENABLE CITY OF HOPE TO ACHIEVE THE HIGHEST LEVELS OF COMMUNITY BENEFIT, IMPACT TO CLINICAL CARE, QUALITY RESEARCH AND EFFICIENT PHILANTHROPIC DEVELOPMENT. UNDER THE AIP AND LTI DESCRIBED IN SCHEDULE J, A SUBSTANTIAL PORTION OF EXECUTIVE COMPENSATION IS LINKED DIRECTLY TO PERFORMANCE GOALS APPROVED IN ADVANCE. AS A RESULT, PERFORMANCE COMPENSATION MAY VARY FROM YEAR TO YEAR. GOAL SETTING UNDER THE AIP IS TIED TO ANNUAL PERFORMANCE, INCLUDING THE ATTAINMENT OF SPECIFIC BUSINESS OBJECTIVES FOR STRATEGIC AND FINANCIAL PERFORMANCE AS WELL AS ON-FINANCIAL MEASURES SUCH AS PATIENT SATISFACTION AND QUALITY OF PATIENT CARE. THE LTI IS DESIGNED TO DRIVE LONG-TERM ORGANIZATIONAL PERFORMANCE AND TRANSFORMATION BY ALIGNING EXECUTIVES WITH THE MULTI-YEAR STRATEGIC PLAN AND INCENTIVIZING THEM TO ACHIEVE KEY ORGANIZATIONAL AND STRATEGIC OBJECTIVES AND GOALS. WITH THREE-YEAR VESTING PERIODS, THE LTI ALSO PROVIDES A MEANS FOR RETAINING KEY EXECUTIVE TALENT. THE COMMITTEE CONDUCTS ANNUAL COMPENSATION REVIEWS FOR THE TOP MANAGEMENT OFFICIAL IN DECEMBER WHERE THE PROPOSED COMPENSATION EXCEEDS COMPENSATION LEVELS ESTABLISHED BY THE COMMITTEE. FORM 990, PART VI, LINE 15B PROCESS TO ESTABLISH COMPENSATION OF OTHER EMPLOYEES THE EXECUTIVE COMPENSATION AND GOVERNANCE COMMITTEE OF THE CITY OF HOPE BOARD OF DIRECTORS ("COMMITTEE") PURSUANT TO A DELEGATION OF AUTHORITY FROM THE CITY OF HOPE BOARD OF DIRECTORS AND THE MEDICAL FOUNDATION BOARD OF DIRECTORS, IS RESPONSIBLE FOR SETTING THE COMPENSATION OF, OR ESTABLISHING COMPENSATION LEVELS FOR TOTAL COMPENSATION CONSISTENT WITH CITY OF HOPE'S COMPENSATION PHILOSOPHY, FOR SENIOR LEADERS AT THE SENIOR VICE PRESIDENT OR EQUIVALENT LEVEL. THE DIRECTORS ON THIS COMMITTEE ARE INDEPENDENT AND ADHERE TO A STRICT CONFLICT OF INTEREST POLICY. DELIBERATION AND DECISION MAKING ARE SUBSTANTIATED IN THE MINUTES OF THE COMMITTEE'S MEETINGS. THE MINUTES ARE REVIEWED AND APPROVED AT THE NEXT MEETING OF THE COMMITTEE. AS PART OF THE DELIBERATION PROCESS, THE COMMITTEE RECEIVES ADVICE FROM AN INDEPENDENT, THIRD-PARTY COMPENSATION CONSULTANT WITH RESPECT TO EXECUTIVE COMPENSATION, INCLUDING REVIEW OF COMPARABLE AND BENCHMARK DATA, CURRENT COMPENSATION PHILOSOPHY, STRUCTURE, AND ADMINISTRATION OF THE EXECUTIVE CASH COMPENSATION PROGRAMS AT CITY OF HOPE AND AFFILIATES. THE COMMITTEE CARRIES OUT THE BOARD OF DIRECTOR'S OVERALL RESPONSIBILITIES RELATING TO EXECUTIVE COMPENSATION. THE EXECUTIVE COMPENSATION PHILOSOPHY IS DESIGNED TO ASSIST IN ATTRACTING AND RETAINING THE CALIBER OF EXECUTIVE LEADERSHIP REQUIRED TO ENABLE CITY OF HOPE TO ACHIEVE THE HIGHEST LEVELS OF COMMUNITY BENEFIT, IMPACT TO CLINICAL CARE, QUALITY RESEARCH AND EFFICIENT PHILANTHROPIC DEVELOPMENT. UNDER THE AIP AND LTI DESCRIBED IN SCHEDULE J, A SUBSTANTIAL PORTION OF EXECUTIVE COMPENSATION IS LINKED DIRECTLY TO PERFORMANCE GOALS APPROVED IN ADVANCE. AS A RESULT, PERFORMANCE COMPENSATION MAY VARY FROM YEAR TO YEAR. GOAL SETTING UNDER THE AIP IS TIED TO ANNUAL PERFORMANCE, INCLUDING THE ATTAINMENT OF SPECIFIC BUSINESS OBJECTIVES FOR STRATEGIC AND FINANCIAL PERFORMANCE AS WELL AS ON-FINANCIAL MEASURES SUCH AS PATIENT SATISFACTION AND QUALITY OF PATIENT CARE. THE LTI IS DESIGNED TO DRIVE LONG-TERM ORGANIZATIONAL PERFORMANCE AND TRANSFORMATION BY ALIGNING EXECUTIVES WITH THE MULTI-YEAR STRATEGIC PLAN AND INCENTIVIZING THEM TO ACHIEVE KEY ORGANIZATIONAL AND STRATEGIC OBJECTIVES AND GOALS. WITH THREE-YEAR VESTING PERIODS, THE LTI ALSO PROVIDES A MEANS FOR RETAINING KEY EXECUTIVE TALENT. THE COMMITTEE CONDUCTS ANNUAL COMPENSATION REVIEWS IN DECEMBER TO SET COMPENSATION LEVELS, OR WHERE THE PROPOSED COMPENSATION EXCEEDS COMPENSATION LEVELS ESTABLISHED BY THE COMMITTEE, COMPENSATION FOR SENIOR LEADERS AT THE SENIOR VICE PRESIDENT OR EQUIVALENT LEVEL. FORM 990, PART VI, LINE 19 REQUIRED DOCUMENTS AVAILABLE TO THE PUBLIC MEDICAL FOUNDATION'S ARTICLES OF INCORPORATION ARE AVAILABLE TO THE PUBLIC FROM THE SECRETARY OF STATE. CITY OF HOPE'S CONSOLIDATED AUDITED FINANCIAL STATEMENTS ARE AVAILABLE ON THE CITY OF HOPE WEBSITE, AND ITS CONFLICT OF INTEREST POLICIES ARE AVAILABLE BY WRITTEN REQUEST MADE TO THE CONFLICT OF INTEREST MANAGER. MEDICAL FOUNDATION'S BYLAWS ARE NOT MADE AVAILABLE TO THE PUBLIC. FORM 990, PART VII, SECTION B, LINE 1, COLUMN (C) COMPENSATION PAID TO INDEPENDENT CONTRACTORS IT IS POSSIBLE THAT A PORTION OF THE AMOUNTS REPORTED FOR CONSTRUCTION SERVICES INCLUDE REIMBURSEMENT FOR EXPENSES, IN ADDITION TO AMOUNTS PAID FOR SERVICES. HOWEVER, THE AMOUNTS ARE NOT DISTINGUISHABLE FROM ONE ANOTHER. FORM 990, PART VII, SECTION A, LINE 1A, COLUMN (B) AVERAGE HOURS PER WEEK DEVOTED FULL TIME EXEMPT EMPLOYEES GENERALLY WORK IN EXCESS OF 40 HOURS PER WEEK, WHICH HAS BEEN REFLECTED IN PART VII BY AN ESTIMATE OF 60 HOURS PER WEEK. THE MEMBERS OF THE BOARD OF DIRECTORS ARE NOT COMPENSATED FOR SERVING ON THE BOARD. THE HOURS DEVOTED FOR EACH DIRECTOR IS AN ESTIMATE OF THE TIME SPENT PREPARING FOR AND ATTENDING MEETINGS OF THE BOARD OF DIRECTORS. THE BOARD OF DIRECTORS OF MEDICAL FOUNDATION HELD FOUR REGULARLY SCHEDULED MEETINGS DURING FISCAL YEAR 2025. THE RISK, AUDIT AND COMPLIANCE COMMITTEE HELD FIVE REGULARLY SCHEDULED MEETINGS IN FISCAL YEAR 2025. FORM 990, PART IX, LINE 11G OTHER FEES PURCHASED SERVICES - TOTAL EXPENSE: XXX-XX-XXXX, PROGRAM SERVICE EXPENSE: XXX-XX-XXXX, MANAGEMENT AND GENERAL EXPENSES: 97124782, FUNDRAISING EXPENSES: ; CONSULTING & MANAGEMENT FEES - TOTAL EXPENSE: 25814594, PROGRAM SERVICE EXPENSE: 19536690, MANAGEMENT AND GENERAL EXPENSES: 6277904, FUNDRAISING EXPENSES: ; REGISTRY & STAFFING FEES - TOTAL EXPENSE: 2351447, PROGRAM SERVICE EXPENSE: 1779594, MANAGEMENT AND GENERAL EXPENSES: 571853, FUNDRAISING EXPENSES: ; BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE 1450 EAST DUARTE ROAD DUARTE CA 91010 953432210 RESEARCH CA 501(C)(3) 4 CITY OF HOPE true CITY OF HOPE 1500 EAST DUARTE ROAD DUARTE CA 91010 953435919 FUNDRAISING CA 501(C)(3) 7 NA false CITY OF HOPE NATIONAL MEDICAL CENTER 1500 EAST DUARTE ROAD DUARTE CA 91010 951683875 HOSPITAL CA 501(C)(3) 3 CITY OF HOPE true COH HOLDCO INC 1500 EAST DUARTE ROAD DUARTE CA 91010 873651176 SUPPORT DE 501(C)(3) TYPE III-FI CITY OF HOPE true MIDWESTERN REGIONAL MEDICAL CENTER INC 1500 EAST DUARTE ROAD DUARTE CA 91010 362510771 HOSPITAL IL 501(C)(3) 3 COH HOLDCO INC true SOUTHEASTERN REGIONAL MEDICAL CENTER INC 1500 EAST DUARTE ROAD DUARTE CA 91010 264572436 HOSPITAL GA 501(C)(3) 3 COH HOLDCO INC true THE TRANSLATIONAL GENOMICS RESEARCH INSTITUTE 445 N 5TH STREET SUITE 600 PHOENIX AZ 85004 753065445 RESEARCH AZ 501(C)(3) 7 CITY OF HOPE true THE TRANSLATIONAL GENOMICS RESEARCH INSTITUTE FOUNDATION 445 N 5TH STREET SUITE 120 PHOENIX AZ 85004 331092191 FUNDRAISING AZ 501(C)(3) 7 TGEN true WESTERN REGIONAL MEDICAL CENTER INC 1500 EAST DUARTE ROAD DUARTE CA 91010 320197974 HOSPITAL AZ 501(C)(3) 3 COH HOLDCO INC true SOUTHERN CALIFORNIA RADIATION ONCOLOGY LLC 1500 EAST DUARTE ROAD DUARTE CA 91010 364887584 RADIATION ONCOLOGY DE COHMF RELATED -1068836 54238715 false false 0.501 ACCESSHOPE LLC 1500 EAST DUARTE ROAD DUARTE CA 91010 842818450 ONCOLOGY SUPPORT DE CITY OF HOPE C CORPORATION false false false true false false false false false false false false true true false true true true false false CITY OF HOPE NATIONAL MEDICAL CENTER C 8000000 BOOK CITY OF HOPE NATIONAL MEDICAL CENTER L 47925500 BOOK CITY OF HOPE NATIONAL MEDICAL CENTER M 23272225 BOOK CITY OF HOPE NATIONAL MEDICAL CENTER O 19893600 BOOK CITY OF HOPE NATIONAL MEDICAL CENTER P 22552257 BOOK CITY OF HOPE NATIONAL MEDICAL CENTER Q 134578035 BOOK SOUTHERN CALIFORNIA RADIATION ONCOLOGY LLC M 24066380 BOOK BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE O 142364 BOOK